| Financial Year |
March 31 2023 |
| Monetary Funds |
4,678,092,731.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,190,708.45 |
| Accounts Receivable |
14,766,563,629.56 |
| Advances to Suppliers |
589,657,092.04 |
| Other Receivables |
2,209,576,915.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
12,177,325.45 |
| Dividend Receivable |
8,125,422.21 |
| Inventories |
2,815,659,420.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
231,781,874.44 |
| Other Current Assets |
531,361,319.18 |
| Total Current Assets |
34,653,533,348.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,724,774,585.86 |
| Long-term Equity Investment |
694,631,110.55 |
| Investment Properties |
571,818,193.05 |
| Fixed Assetes |
2,275,262,751.11 |
| Under-construction Projects |
198,007,446.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,229,954,647.31 |
| R&D expenses |
3,823,008.84 |
| Goodwill |
875,128.92 |
| Long-Term Deferred and Prepaid Expenses |
42,715,438.52 |
| Deferred Income Tax Assets |
998,832,683.86 |
| Other Non-Current Assets |
1,226,390,581.96 |
| Sub-Total of Non-Current Assets |
9,034,162,854.07 |
| Total Assets |
43,687,696,202.24 |
| Short-Term Loans |
3,131,703,304.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,082,060,083.27 |
| Accounts Payable |
11,810,973,652.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
188,032,006.40 |
| Taxes Payable |
159,811,789.86 |
| Interest Payable |
-- |
| Dividend Payable |
2,408,891.77 |
| Other payables |
1,926,903,358.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,252,633,215.54 |
| Other Current Liabilities |
1,633,366,728.43 |
| Sub-Total of Current Liabilities |
27,993,513,361.73 |
| Long-term Loans |
4,504,976,754.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,939,611.80 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
72,247,308.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,211,616,841.07 |
| Total Liabilities |
33,205,130,202.80 |
| Paid-In Capital(Or Share Stock) |
2,959,066,667.00 |
| Capital Surplus |
919,256,699.11 |
| Surplus Reserve |
229,735,034.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
602,059,387.06 |
| Minority Stockholder's Interest |
2,967,368,894.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,515,197,105.39 |
| Owner's Equity（Stockholder's Equity） |
10,482,565,999.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
43,687,696,202.24 |
